Clinical Trial Update: Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 multiple-dose, parallel-group study evaluating AMA0076 in patients with primary open-angle glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AMA0076

Snippet

Sponsor: Amakem, NV | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED